Skip to main content

EDITORIAL article

Front. Endocrinol.
Sec. Cancer Endocrinology
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1527867
This article is part of the Research Topic Unraveling the Complex Interplay Between Aging, Immunity, Metabolites, and Metabolism in Endocrine-Related Cancers View all 9 articles

Editorial: Exploring the Interplay of Aging, Immunology, and Metabolic Pathways in Endocrine-Related Cancers

Provisionally accepted
Guang-Liang Chen Guang-Liang Chen 1,2*Yubin Luo Yubin Luo 3Yuwei Zhang Yuwei Zhang 3Chao Liu Chao Liu 4
  • 1 Shanghai Cancer Center, Fudan University, Shanghai, China
  • 2 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
  • 3 West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
  • 4 Department of Cancer Immunology and Virology, Dana–Farber Cancer Institute, Boston, Massachusetts, United States

The final, formatted version of the article will be published soon.

    A notable study by Feng et al. on metabolic reprogramming in gastric cancer introduces a robust metabolic model that categorizes patients based on metabolic activity, uncovering critical links to prognosis (https://doi.org/10. 3389/fendo.2023.1228136). This approach to metabolic profiling highlights the value of integrating metabolic states into tailored treatment strategies, advancing personalized care for gastric cancer patients. We are pleased to note that certain studies within this collection have already garnered multiple citations shortly after publication, underscoring their pivotal impact and relevance across various scientific fields. This citation pattern highlights how these findings are shaping current research directions and informing future investigations, particularly in the interconnected areas of aging, immunology, and metabolism.Collectively, these articles underscore the critical need for interdisciplinary approaches to drive advancements in endocrine-related cancer research. By integrating perspectives from aging, immunology, and metabolic science, this Research Topic lays a foundation for precision medicine, fostering innovations that address the intricate biological landscapes of endocrine-related cancers.

    Keywords: Endocrine-related cancers, Aging, metabolic, breast cancer, immune, Mendelian randomization

    Received: 13 Nov 2024; Accepted: 15 Nov 2024.

    Copyright: © 2024 Chen, Luo, Zhang and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Guang-Liang Chen, Shanghai Cancer Center, Fudan University, Shanghai, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.